• Home
  • Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer.

Author List
Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B
Publication
JCI insight
Publication ID (Profile URL)
https://researcherprofiles.org/profile/26095667
Publication Year
2018
PubMed ID
30185663
Publication Title
Su Y, Liu Y, Behrens CR, Bidlingmaier S, Lee NK, Aggarwal R, Sherbenou DW, Burlingame AL, Hann BC, Simko JP, Premasekharan G, Paris PL, Shuman MA, Seo Y, Small EJ, Liu B. Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer. JCI Insight. 2018 09 06; 3(17).